Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NIH launches last trial of anticoagulant treatments for Covid-19

pharmaceutical-technologyMarch 10, 2021

Tag: NIH , COVID-19 , anticoagulant , ACTIV-4

PharmaSources Customer Service